People-Centred HCV Care: Simply Delivered
13.15 – 14.00 PM BST
Wednesday 19 October 2022
What challenges do individuals with hepatitis C (HCV) encounter on the journey from diagnosis to cure? How can these challenges be overcome to simply deliver HCV care to all who need it?
Join us at the 10th International Conference on Health and Hepatitis Care in Substance Users (INHSU 2022) to hear a first-hand account of lived HCV experience and what simplification of the HCV care cascade really means to those directly affected by this disease. The non-promotional symposium, organized and funded by AbbVie, “People-Centred HCV Care: Simply Delivered,” will feature renowned speakers Prof. Ashley Brown and Ms. Lesley Gallagher as they share their expert perspective on the HCV journey, the progress being made, and the challenges still being faced. Also featured will be a pre-recorded peer interview followed by live reactions from our speakers on what is needed to continue the drive towards HCV elimination.
Point of Care HCV RNA diagnostics Improve Test and Treat Pathways
8.00AM – 8.45 AM BST
Thursday 20 October 2022
Innovative models of care for HCV in delivered in community settings are needed to engage marginalised people to be tested and linked to care. In this symposium, speakers share experiences of how implementing POC HCV RNA testing can benefit diagnostic pathways and engagement in treatment and care.
Right here, right now: strategies to enhance the HCV care cascade
12.45 – 13.45 PM BST
Thursday 20th October 2022
Join Jason Grebely, John Dillon, Rachel Halford and Mim O’Flynn for the Gilead-sponsored symposium ‘Right here, right now: strategies to enhance the HCV care cascade’, taking place from 12.45–13.45 BST on Thursday 20 October 2022, during the 10th International Conference on Health and Hepatitis Care in Substances Users.
The simplification of the HCV care cascade has enabled more people living with HCV to access the care they need, but further progress is needed to meet the WHO target for global elimination of viral hepatitis by 2030.
In this symposium, the panel will discuss strategies to enhance the HCV care cascade so that treatment can be provided for all patients in front of us. The expert faculty will discuss how simplified diagnostics and motivating providers to offer best practice in HCV care can improve healthcare engagement, particularly among marginalised individuals, and empower patients to get the care they deserve.